Potential of Intestinal Current Measurement for Personalized Treatment of Patients with Cystic Fibrosis

Refinement of personalized treatment of cystic fibrosis (CF) with emerging medicines targeting the CF basic defect will likely benefit from biomarkers sensitive to detect improvement of cystic fibrosis transmembrane conductance regulator (CFTR) function in individual patients. Intestinal current mea...

Descripción completa

Detalles Bibliográficos
Autores principales: Graeber, Simon Y., Vitzthum, Constanze, Mall, Marcus A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8151208/
https://www.ncbi.nlm.nih.gov/pubmed/34066648
http://dx.doi.org/10.3390/jpm11050384

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8151208/
https://www.ncbi.nlm.nih.gov/pubmed/34066648
http://dx.doi.org/10.3390/jpm11050384

Ejemplares similares